Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 19 Jan 2026 for Innate Pharma, €81k. Read the official filing
Filing timeline
BuySaleNicola Beltraminelli
Insider track record
Disclosed buys
2
Disclosed sells
1
Signal history
Closed purchases
Market purchases
2
Positive at T+90
0%
Median T+90
-15.1%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -14.7%Entry €1.48 · Close 14 Oct 2026 €1.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nicola Beltraminelli: trading record in brief
Nicola Beltraminelli (senior executive) discloses dealings in Innate Pharma to AMF. Between 31 December 2025 and 5 January 2026, the trades on record add up to 3 filings.
In open-market terms, that means 2 purchases worth €161k on one side and 1 sale worth €4,710 on the other. Netting one side against the other leaves €156k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 2 purchases and 1 sale.
Most recently, on 19 January 2026, the filings show an open-market purchase worth €81k in Innate Pharma. Filings reach the AMF feed a median of 19 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from AMF. Past trades are no guide to future returns.
Companies and markets linked to Nicola Beltraminelli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
50,000 shares@ €1.61648.7% of flowActionEuronext ParisISIN FR00103314212026DD1086888
Canonical exit: 31 Mar 2026 (T+90)
50,000 shares@ €1.60848.5% of flowActionEuronext ParisISIN FR00103314212026DD1089552
Canonical exit: 31 Mar 2026 (T+90)
3,000 shares@ €1.572.8% of flowActionEuronext ParisISIN FR00103314212026DD1088617
3 of 3 declarations
